Drug Shortage Report for COPHYLAC
Report ID | 101027 |
Drug Identification Number | 02224577 |
Brand name | COPHYLAC |
Common or Proper name | COPHYLAC |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | NORMETHADONE HYDROCHLORIDE P-HYDROXYEPHEDRINE HYDROCHLORIDE |
Strength(s) | 10MG 20MG |
Dosage form(s) | DROPS |
Route of administration | ORAL |
Packaging size | 15ml |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2020-02-11 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-08-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-11 | English | Compare |
v2 | 2019-12-11 | French | Compare |
v3 | 2020-01-21 | English | Compare |
v4 | 2020-01-23 | English | Compare |
v5 | 2020-01-23 | French | Compare |
v6 | 2020-01-25 | English | Compare |
v7 | 2020-02-14 | English | Compare |
v8 | 2020-02-14 | French | Compare |
v9 | 2020-05-13 | English | Compare |
v10 | 2020-05-13 | French | Compare |
v11 | 2021-08-03 | English | Compare |
v12 | 2021-08-03 | English | Compare |
v13 | 2021-08-03 | French | Compare |
Showing 1 to 13 of 13